1. Home
  2. ARTL vs AGMH Comparison

ARTL vs AGMH Comparison

Compare ARTL & AGMH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ARTL
  • AGMH
  • Stock Information
  • Founded
  • ARTL 2011
  • AGMH 2015
  • Country
  • ARTL United States
  • AGMH Hong Kong
  • Employees
  • ARTL N/A
  • AGMH N/A
  • Industry
  • ARTL Biotechnology: Pharmaceutical Preparations
  • AGMH EDP Services
  • Sector
  • ARTL Health Care
  • AGMH Technology
  • Exchange
  • ARTL Nasdaq
  • AGMH Nasdaq
  • Market Cap
  • ARTL 3.1M
  • AGMH 3.5M
  • IPO Year
  • ARTL N/A
  • AGMH 2018
  • Fundamental
  • Price
  • ARTL $9.76
  • AGMH $2.62
  • Analyst Decision
  • ARTL Buy
  • AGMH
  • Analyst Count
  • ARTL 2
  • AGMH 0
  • Target Price
  • ARTL $30.00
  • AGMH N/A
  • AVG Volume (30 Days)
  • ARTL 1.4M
  • AGMH 575.4K
  • Earning Date
  • ARTL 08-12-2025
  • AGMH 07-15-2025
  • Dividend Yield
  • ARTL N/A
  • AGMH N/A
  • EPS Growth
  • ARTL N/A
  • AGMH N/A
  • EPS
  • ARTL N/A
  • AGMH 6.43
  • Revenue
  • ARTL N/A
  • AGMH $32,044,575.00
  • Revenue This Year
  • ARTL N/A
  • AGMH N/A
  • Revenue Next Year
  • ARTL N/A
  • AGMH N/A
  • P/E Ratio
  • ARTL N/A
  • AGMH $0.37
  • Revenue Growth
  • ARTL N/A
  • AGMH N/A
  • 52 Week Low
  • ARTL $4.92
  • AGMH $1.09
  • 52 Week High
  • ARTL $25.58
  • AGMH $109.50
  • Technical
  • Relative Strength Index (RSI)
  • ARTL 60.38
  • AGMH 46.10
  • Support Level
  • ARTL $9.11
  • AGMH $2.16
  • Resistance Level
  • ARTL $13.22
  • AGMH $2.59
  • Average True Range (ATR)
  • ARTL 1.83
  • AGMH 0.33
  • MACD
  • ARTL 0.47
  • AGMH 0.07
  • Stochastic Oscillator
  • ARTL 21.64
  • AGMH 77.05

About ARTL Artelo Biosciences Inc.

Artelo Biosciences Inc is a United States-based development-stage biopharmaceutical company. It is engaged in the development of therapeutics that target lipid signaling pathways, including the endocannabinoid system, a family of receptors & neurotransmitters that form a biochemical communication network in the body. It is focused on discovering, licensing, developing, & commercializing treatments that control endocannabinoid systems. The company pursues technologies & programs that offer proprietary approaches to cannabinoid-based therapies, & those derived from the cannabis plant & synthetic cannabinoids, as well as new chemical entities & compounds. The firm's flagship program is designed to be a patent-protected cannabinoid drug combination treatment for a rare & orphan disease.

About AGMH AGM Group Holdings Inc.

AGM Group Holdings Inc is an investment holding company. The company focuses on blockchain-oriented ASIC chip design; high-end crypto miner production and fintech technology software service. It generates maximum revenue from the sale of cryptocurrency mining machines and standardized computing equipment.

Share on Social Networks: